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 ORIGINAL ARTICLE 
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 Abstract 
 Objective. To identify inappropriate prescribing among older patients on admission to and discharge from an intermediate-
care nursing home unit and hospital wards, and to compare changes during stay within and between these groups. 
Design. Observational study.  Setting and subjects. Altogether 400 community-dwelling people aged    70 years, on consecutive 
emergency admittance to hospital wards of internal medicine and orthopaedic surgery, were randomized to an intermediate-
care nursing home unit or hospital wards; 290 (157 at the intermediate-care nursing home unit and 133 in hospital wards) 
were eligible for this sub-study.  Main outcome measures. Prevalence on admission and discharge of potentially inappropriate 
medications (Norwegian general practice [NORGEP] criteria) and drug – drug interactions; changes during stay.  Results. 
The mean (SD) age was 84.7 (6.2) years; 71% were women. From admission to discharge, the mean numbers of drugs 
prescribed per person increased from 6.0 (3.3) to 9.3 (3.8), p    0.01. The prevalence of potentially inappropriate medica-
tions increased from 24% to 35%, p    0.01; concomitant use of    3 psychotropic/opioid drugs and drug combinations 
including non-steroid anti-infl ammatory drugs (NSAIDs) increased signifi cantly. Serious drug – drug interactions were 
scarce both on admission and discharge (0.7%).  Conclusions. Inappropriate prescribing was prevalent among older people 
acutely admitted to hospital, and the prevalence was not reduced during stay at an intermediate-care nursing home unit 
specially designed for these patients. 
 Key Words: Acute illness ,  drug – drug interactions ,  elderly ,  general practice ,  hospital ,  intermediate care unit ,  NORGEP screening tool , 
 Norway ,  potentially inappropriate medications 
 Introduction 
 Community-dwelling older people are treated with 
on average 2.8 to 5.0 drugs [1,2]. Due to age-related 
changes and drug interactions, they are at increased 
risk of adverse drug events. 
 Inappropriate drug prescribing can be defi ned 
as medication for which the risks outweigh the benefi ts 
[3,4]. Based on the widely cited Beers ’ criteria for 
drugs to avoid for older people [5], the prevalence of 
potentially inappropriate medications (PIMs) ranged 
from 18% to 42% in the community [4]. However, 
almost half the drugs meeting Beers ’ criteria are 
unavailable outside the United States; consequently, 
other criteria have been established in European 
countries, such as the Norwegian general practice 
(NORGEP) [6] criteria. 
 Frail older people are at risk of acute health 
deterioration that may necessitate emergency hospi-
tal admission. Hospital departments are becoming 
increasingly specialized, while the length of stay 
is declining. Older people with complex health 
problems often need more comprehensive treatment 
and rehabilitation than hospital departments can 
provide. To close the gap between hospitals and 
primary health care, various types of intermediate-
care units have been developed [7]. Studies sug-
gest that these units may reduce readmissions to 
hospital and improve survival [7 – 9]. Treatment in an 
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intermediate-care nursing home unit (INHU) is 
based on a multidisciplinary geriatric approach 
under the guidance of a specialist in geriatrics and 
may possibly provide better conditions than hospital 
wards (HWs) for improving the quality of drug 
prescribing. 
 On the instructions of the Municipality of 
Bergen, Norway, an open randomized study was 
conducted to evaluate a recently established INHU. 
Community-dwelling older people acutely admitted 
to hospital were randomly assigned to treatment in 
the INHU or in HWs. Retrospectively we designed 
the present study aiming to identify inappropriate 
prescribing on admission and discharge, and to 
compare changes during stay within and between 
the study groups. 
 Material and methods 
 Setting 
 Two hospitals provide emergency treatment in 
Bergen (about 250 000 inhabitants). The INHU pro-
vides health care to inhabitants aged    70 years after 
discharge from hospital departments of internal 
medicine or orthopaedic surgery. Patients are eligible 
for the INHU if transferrable within 72 hours after 
emergency admission and dischargeable from the 
INHU to their residence within three weeks. Patients 
who need surgery or intensive care, and those with 
delirium or severe dementia, are not eligible. The INHU 
provides a multidisciplinary geriatric approach, with 
physicians, nurses, and physiotherapists more avail-
able than in regular nursing home units. Essentially, 
treatment in the INHU is targeted at rehabilitation, 
nutrition, and medication review; however, the 
procedures are not standardized. 
 Study population 
 From August 2007 to June 2008, 400 patients were 
consecutively recruited on emergency hospital admis-
sion. Randomization was performed at each hospital; 
200 patients were assigned to the INHU and 200 to 
HWs. In this substudy, 290 patients (157 in the 
INHU and 133 in HWs) were included. Patients 
were regarded as ineligible if not retrospectively 
identifi able in the hospital data systems (n    10), 
medication lists were unavailable (n    6), consent 
was withdrawn (n    14), or due to practical and 
administrative errors early in the study period, such 
as patients not actually meeting the inclusion criteria 
or being randomized twice (n    80). 
 Data collection 
 Charged by the Municipality of Bergen, a private 
research institute (Agenda Musemann) performed 
inclusion, randomization, and data collection. We 
obtained the following variables; patients ’ age and 
sex, setting (INHU or HW), length of stay, all 
medications used regularly and  “ as required ” on 
admission and discharge. Medications were coded 
according to the Anatomical Therapeutic Chemical 
(ATC) classifi cation system [10]. 
 Inappropriate prescribing 
 As clinical information was not available, patients ’ 
medication lists were screened according to the 
explicit NORGEP criteria [6], comprising 21 single 
drugs and 15 drug combinations considered inap-
propriate for community-dwelling people aged    70 
years, regardless of their clinical condition (Table I). 
Two NORGEP-listed drugs have been withdrawn 
from the Norwegian market, leaving 34 eligible 
criteria. Medication lists were screened for drug –
 drug interactions (DDIs) listed in a Norwegian 
interactive database (DRUID) [11]. DDIs were 
classifi ed on a four-point severity scale: (A) of aca-
demic interest; (B) take precautions; (C) should be 
administration 2 – 3 hours apart; and (D) should not 
be combined [11]. 
 Statistical analysis 
 A chi-squared test (categorical data) and Student ’ s 
t-test (continuous data) were used to compare pre-
valence of drug use, PIMs, and DDIs on admission 
and discharge, within and between study groups. 
Logistic regression was performed to compare 
changes regarding drug use, PIMs, and DDIs from 
admission to discharge, between HW and INHUs 
(adjusted for patients ’ age, sex and drug use, PIMs, 
and DDIs on admission). We considered p    0.05 to 
 Older people are at increased risk of adverse 
drug events. Screening tools may identify 
potentially inappropriate medications. Treat-
ment in intermediate care units may possibly 
provide an opportunity for reducing inappro-
priate prescribing. 
 Inappropriate prescribing was prevalent  •
among community-dwelling older people 
on emergency admittance to hospitals in 
Bergen, Norway. 
 Concomitant use of   •   3 psychotropic/opioid 
drugs and drug combinations including non-
steroid anti-infl ammatory drugs (NSAIDs) 
increased signifi cantly during stay. 
 Serious drug – drug interactions were scarce  •
on admission and discharge. 
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 Table I. Potentially inappropriate medications (PIMs) identifi ed on admission to and discharge from intermediate care 
nursing home unit (INHU) and hospital ward (HW). 
NORGEP criteria
INHU 
admission
 (n    157)
%
INHU 
discharge
 (n    157)
%
HW 
admission
 (n    133)
%
HW 
discharge
 (n    133)
%
All patients
 admission
 (n    290)
%
All patients
 discharge
 (n    290)
%
1. Amitriptyline 1.3 0.6 2.3 2.3 1.7 1.4
2. Doxepin 0.6 0.6 0 0 0.3 0.3
3. Clomipramine 0.6 0.6 0 0 0.3 0.3
4. Trimipramine 0 0 0 0 0 0
5. Chlorpromazine 1 0 0 0 0 0 0
6. Chlorprothixene 0 0 0 0 0 0
7. Levomepromazine 0 0 0 0 0 0
8. Prochlorperazine 1.3 1.9 3.0 3.0 2.1 2.4
9. Diazepam 4.5 4.5 5.3 11.3 4.8 7.6
10. Nitrazepam 4.5 3.2 2.3 3.0 3.4 3.1
11. Flunitrazepam 0 0 0 0 0 0
12. Oxazepam 30 mg/24 h 1.9 5.7 0 0 1.0 3.1
13. Zopiclone 7.5 mg/24 h 0.6 0.6 0 0 0.3 0.3
14. Carisoprodol 1 0 0 0 0 0 0
15. Dextropropoxyphene 2.5 2.5 0.8 0.8 1.7 1.7
16. Theophylline 0.6 0.6 1.5 1.5 1.0 1.0
17. Sotalol 0 0 0 0 0 0
18. Dexchlorfeniramine 0 0.6 0 0 0 0.3
19. Promethazine 0 0 0 0 0 0
20. Hydroxyzine 0.6 1.9 0 0 0.3 1.0
21. Alimemazine 0 0 0 1.5 0 0.7
22. Warfarin   NSAID 0.6 0.6 0 0 0.3 0.3
23. Warfarin   ofl oxacin or ciprofl oxacin 0 0 1.5 2.3 0.7 1.0
24. Warfarin   erythromycin or clarithromycin 0 0 0 0 0 0
25. Warfarin   SSRI 1.9 3.2 3.8 3.0 2.8 3.1
26. NSAID/coxib   ACE inhibitor/ARB 2.5 5.1 1.5 1.5 2.1 3.4
27. NSAID   diuretic 1.3 3.2 0 2.3 0.7 2.8
28. NSAID   glucocorticoid 0 1.3 0 1.5 0 1.4  ∗  
29. NSAID   SSRI 0 3.2 0 0.8 0 2.1∗∗
30. Erythromycin or clarithromycin   statin 1.3 0 0 0 0.7 0
31.  ACE inhibitor   potassium or potassium-
sparing
1.3 1.3 3.8 5.3 2.4 3.1
32. Fluoxetine or fl uvoxamine   TCA 0 0 0 0 0 0
33.  Beta blocker   cardioselective calcium 
antagonist
0 0 0 0 0 0
34. Diltiazem   lovastatin or simvastatin 0.6 0.6 0 0 0.3 0.3
35.  Erythromycin or 
clarithromycin   carbamazepine
0 0 0 0 0 0
36.  Concomitant prescription of three or 
more drugs within the groups centrally 
acting analgesics, antipsychotic agents, 
antidepressants and/or benzodiazepines
4.5 14.0  ∗∗  2.3 12.8  ∗∗  3.4 13.4∗∗
Any NORGEP criterion 25.5 33.1 22.6 36.8  ∗∗  24.l 34.8  ∗∗  
 Notes: NSAID   non-steroidal anti-infl ammatory drug; SSRI   selective serotonin reuptake inhibitor; ACE angiotensin-converting 
enzyme; ARB   angiotensin-receptor blocker; TCA   tricyclic antidepressant.  1 Withdrawn from the Norwegian market. Chi-squared test 
with Yates ’ correction for changes from admission to discharge; Fisher if    5 expected cases;   ∗  p    0.05;   ∗∗  p    0.01. Logistic regression 
was not conducted due to multiple empty cells, and very small numbers in most remaining cells. 
be statistically signifi cant. PASW version 17 software 
was used. 
 Results 
 The 290 study participants (71% women) had a 
mean (SD) age of 84.7 (6.2) years. Patients in the 
INHU and HWs did not differ signifi cantly regarding 
age, sex, or drug use on admission. The mean length 
of stay was 21 days in the INHU, 10 days in the HW 
(p    0.01). 
 Drug use 
 The mean (SD) number of drugs used increased 
from 6.0 (3.3) per patient on admission to 9.3 (3.8) 
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on discharge (p    0.01); regular drugs increased from 
5.6 (3.2) to 7.3 (3.3), and drugs used  “ as required ” 
from 0.4 (0.8) to 2.0 (1.6), both p    0.01. Increased 
drug use was mainly caused by more prescribing 
of antiemetics, laxatives, antibiotics, analgesics, 
anxiolytics, hypnotics/sedatives, and cough and cold 
medications, all p    0.01 (Table II). 
 Compared with patients in HWs, INHU patients 
were less likely to use antithrombotic agents (odds 
ratio (OR)    0.36, 95% confi dence interval (CI) 
0.16 – 0.78) and antibiotics (OR    0.32, 95% CI 
0.17 – 0.60) at discharge and more likely to use non-
opioid analgesics (OR    2.20, 95% CI 1.32 – 3.67) 
and cough and cold medications (OR    2.24, 95% 
CI 1.09 – 4.61) (see Table I). 
 Potentially inappropriate medications 
 We identifi ed 23 out of 34 NORGEP criteria in our 
study population (see Table I). The prevalence of 
using any PIM increased from 24% on admission 
(20% men, 26% women), to 35% on discharge 
(p    0.01), due to more PIMs in HWs (p    0.02) but 
not in the INHU (p    0.2) . Concomitant use of    3 
psychotropic/opioid drugs was the criterion most 
frequently identifi ed and increased from admission 
 Table II. Prevalence of drug use on admission and discharge, and changes in drug use during stay, within and between 
study groups. 
ATC code Drug group
All
 patients
 admission
 (n    290)
%
All
 patients
 discharge
 (n    290 1 )
%
HW
 discharge
 (n    133)
%
INHU
 discharge
 (n    157)
%
Comparison of the change in 
drug use from admission to 
discharge between HW and 
INHU 2 
Odds 
ratio
95% Confi dence 
interval
A02 Drugs for acid-related disorders 20.3 24.5 26.3 22.9 0.80 0.32 – 2.17 
A03 Drugs for functional gastrointestinal 
disorders
1.4 20.7 ∗ ∗ 21.8 19.7 0.85 0.47 – 1.53
A06 Laxatives 12.4 45.2 ∗ ∗ 41.4 48.4 1.57 0.94 – 2.62
A11 Vitamins 10.0 15.5 ∗ 15.0 15.9 1.70 0.61 – 4.64
A12 Minerals 20 27.9 ∗ 26.3 29.3 1.03 0.48 – 2.23
B01 Antithrombotic agents 59.0 64.5 72.2 58.0 0.36 0.16 – 0.78
B03 Anti-anaemic preparations 14.1 19.0 16.5 21.0 1.44 0.54 – 3.88
C01 Cardiac therapy 23.1 25.2 26.3 24.2 0.76 0.29 – 2.00
C03 Diuretics 39.7 42.1 45.9  3.8 0.76 0.26 – 2.18
C07 Beta-blocking agents 40.0 42.4 44.4 40.8 0.44 0.15 – 1.35
C08 Ca 2   channel blockers 16.9 18.6 21.8 15.9 4.16 0.91 – 19.02
C09 Agents acting on the renin-
angiotensin system
38.6 36.6 36.8 36.3 1.12 0.48 – 2.59
C10 Lipid-modifying agents 27.6 29.0 27.1 30.6 0.89 0.12 – 6.51
H03 Thyroid therapy 15.5 25.9 12.0 17.8  – 
J01 Antibacterial agents for systemic use 10.0 21.4 ∗ ∗ 29.3 14.6 0.32 0.17 – 0.60
M01 Anti-infl ammatory and anti-
rheumatic products, including 
non-steroids
4.1 9.7 ∗ ∗  6.8 12.1 0.67 0.28 – 1.61
M others Musculoskeletal system; other drugs 13.4 15.9 18.0 14.0 1.35 0.32 – 5.69
N02A Analgesics: opioids 15.9 49.0 ∗ ∗ 51.1 47.1 0.91 0.55 – 1.52
N02B Analgesics: other analgesics and 
antipyretics
15.9 60.3 ∗ ∗ 51.9 67.5 2.20 1.32 – 3.67
N05A Psycholeptics: antipsychotics 3.8 5.5  6.0  5.1 1.0 0.25 – 3.91
N05B Psycholeptics; anxiolytics 11.0 19.0 ∗ ∗ 18.0 19.7 1.37 0.59 – 3.18
N05C Psycholeptics: hypnotics and 
sedatives
23.8 49.0 ∗ ∗ 47.4 50.3 1.19 0.68 – 2.01
N06A Psychoanaleptics: antidepressants 16.2 17.6 15.0 19.7 1.65 0.38 – 7.16
R03 Drugs for obstructive airway disease 14.8 19.3 16.5 21.7 1.32 0.48 – 3.60
R05 Cough and cold preparations 3.8 17.9 ∗ ∗ 13.5 21.7 2.24 1.09 – 4.61
S01 Ophthalmologicals 11.7 17.6 ∗ 18.0 17.2 2.59 0.89 – 7.50
 Notes: INHU   intermediate nursing home unit; HW   hospital ward.  1 Test of overall change in proportion of drug use from admission 
to discharge (chi-squared test, Fisher if    5 expected cases).  2 Logistic regression, adjusted for age, sex, and drugs used on admission 
(reference: INHU).  ∗ p    0.05,  ∗∗ p    0.01. 
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to discharge (p    0.01), mainly due to enhanced use 
of anxiolytics and hypnotics/sedatives. The prevalence 
of inappropriate drug combinations increased for 
NSAIDs   steroids (p    0.05) and NSAIDs   selec-
tive serotonin reuptake inhibitors (SSRIs) (p    0.01). 
No signifi cant reduction in any criterion could be 
identifi ed. Patients in the INHU were less likely than 
HW patients to start treatment with diazepam 
(OR    0.17, 95% CI 0.04 – 0.79, not shown in table). 
 Drug – drug interactions 
 Serious DDIs (class D) were scarce (0.7% on admis-
sion and discharge); clarithromycin   simvastatin 
(n    1), warfarin   NSAIDs (n    2), trimethoprim/
sulphamethoxazole   methotrexate (n    1). Less 
serious DDIs increased signifi cantly (Table III), but 
there were no signifi cant differences between study 
groups. Generally, being exposed to a certain DDI 
on admission was the strongest predictor of this 
DDI at discharge (not shown in table). Prevalence of 
DDIs did not differ signifi cantly between genders. 
 Discussion 
 On admission, every fourth patient was exposed to 
inappropriate prescribing, and prevalence increased 
during the stay in both INHU and HWs. 
 Strengths and limitations 
 To our knowledge, this is the fi rst study examining 
inappropriate prescribing in an INHU. NORGEP, 
tailored for community-dwelling older persons, and 
DRUID provide the advantage of being based on the 
national drug formulary. Although the design was 
appropriate to examine drug therapy changes during 
the stay in INHU and HWs, the main study was not 
designed for assessing difference in inappropriate 
prescribing between these units. We have included 
patients ’ complete medication lists. Prescribing of drugs 
used  “ as required ” increased from 0.4 on admittance 
to 2.0 on discharge, indicating that most of these 
drugs were initiated for the treatment of actual symp-
toms; we have no reasons to believe that these drugs 
have not been used. The most important limitation 
was the lack of clinical information. Consequently, 
the reasons for drug therapy changes made could 
not be examined. Assessing drugs prescribed for spe-
cifi c diagnoses, or structured medication reviews 
[1,12,13], would have provided a more comprehen-
sive picture, including overprescribing, underpre-
scribing, and incorrect prescribing. 
 Drug utilization 
 Drug utilization studies among community-dwelling 
older people are scarce, and comparison is hampered 
by differences in study population, data source, and 
criteria for inappropriate prescribing; prevalence 
fi gures should therefore be interpreted with caution. 
 Our study population used on average 5.6 regular 
drugs versus 2.8 regular drugs used by the general 
community-dwelling population aged 70 – 74 years 
in the same county in Norway [14] and 5.0 drugs 
used by people on average aged 78 years on acute 
hospital admission in Ireland [1]. Increased drug 
use during the study period was mainly due to treat-
ment of infections and pain that may have caused 
the actual hospital admissions. Earlier discharge 
from the HW may explain group differences on dis-
charge regarding antibiotics and antithrombotic 
agents, while more use of non-opioid analgesics or 
cough and cold medications in the INHU may refl ect 
more symptomatic treatment during longer stays. 
 Table III. Drug – drug interactions identifi ed on admission to and discharge from 
intermediate-care nursing home unit (INHU) and hospital ward (HW). 
 Drug–drug 
interaction 
(DRUID)
 severity scale
HW
 admission
 (n    133)
%
HW
 discharge
 (n    133)
%
INHU
 admission
 (n    157)
%
INHU
 discharge
 (n    157)
%
All patients
 admission
 (n    290)
%
All patients
 discharge
 (n    290)
%
A 31.6 44.4  ∗  24.8 39.5  ∗ ∗  27.9 41.7  ∗ ∗  
B 39.8 54.1  ∗  40.1 46.5 40.0 50.0  ∗  
C  8.3 12.8  6.4 11.5  7.2 12.1  ∗  
D 0 0  1.3  1.3  0.7  0.7
Any drug–drug 
interaction
54.9 67.7  ∗  52.9 66.9  ∗ ∗  53.8 67.7  ∗ ∗ 
 Notes: A   of academic interest; B   take precautions; C   should be administered 2 – 3 hours apart; 
D   should not be combined. Chi-squared test for changes from admission to discharge; Fisher if    5 
expected cases;   ∗  p    0.05;   ∗∗  p    0.01. Logistic regression did not reveal signifi cant differences between 
study groups; results are not shown. 
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 Inappropriate prescribing 
 Based on NORGEP we found a 24% point preva-
lence of PIMs on acute hospital admission versus 
a 35% one-year prevalence among the general 
Norwegian population 70 years and older in 2008 
[15]. The prevalence of PIMs in our study was in 
accordance with comparable studies regarding long-
acting benzodiazepines, multiple psychotropic drugs, 
anticholinergic drugs, and NSAIDs [2,14 – 21]. These 
PIMs are clinically signifi cant due to the increased 
risk of adverse side effects; extensive use of psycho-
tropic drugs leads to sedation, cognitive decline, 
delirium, and falls; use of NSAIDs by older people 
may induce renal failure, congestive heart failure, 
and gastrointestinal bleeding. The high overall DDI 
prevalence in this study supports previous studies 
on older inpatients [22,23]. The increase in DDIs 
during stay is explained by increased overall drug 
use [24]. However, one might question the clinical 
relevance, because serious DDIs were scarce in our 
as in other studies [24 – 26]. 
 In Norway, GPs have an overall responsibility 
for coordinating drug therapy for the patients on 
their list. However, older people with complex health 
problems are commonly exposed to prescribing 
from several doctors, e.g. out-of-hours services and 
specialists; this represents challenges to ensure 
overall prescribing quality. About 20% of hospital 
admissions of older patients are caused by drug-
related problems, most of which are considered 
preventable [27]. An ongoing Norwegian patient 
safety campaign recommends that structured 
medica tion reviews based on patients ’ individual 
clinical characteristics and feasible tools [12] should 
be conducted when the patients ’ clinical situation is 
altered, and when the patients are transmitted 
between different health care levels [28]. Questions 
might be raised as to whether these requirements 
can be met during short hospital stays; however, 
appropriate drug therapy changes for the acute con-
ditions, and withdrawal of obviously dangerous 
medications, should always be conducted. A ran-
domized controlled trial revealed more appropriate 
drug treatment in a geriatric evaluation and 
management unit than in general medical wards 
[29]. Consequently, one might expect that a specially 
designed INHU for older people with complex 
health problems could reduce inappropriate pre-
scribing. We can only speculate why this was not 
the case in this study; possibly INHU physicians 
were reluctant to interfere with the decisions of 
patients ’ GPs. Further, we had no information on 
written recommendations for drug therapy changes 
that were provided to patients ’ GPs on discharge. 
 Implications 
 INHUs have just recently been established in 
Norway, providing a broad multidisciplinary geria-
tric approach to older people with complex health 
problems and extensive drug use. Further research 
is needed to evaluate how these units can contribute 
to reducing inappropriate prescribing in cooperation 
with patients ’ GPs, along with geriatric hospital 
wards and geriatric outpatient clinics. Studies, pri-
marily designed to assess how inappropriate pre-
scribing affects health outcomes, are needed [30]. 
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